Literature DB >> 3193177

Evidence for the presence of serotonergic nerves and receptors in the iris-ciliary body complex of the rabbit.

A B Tobin1, W Unger, N N Osborne.   

Abstract

The rabbit iris-ciliary body contains 78 +/- 6 ng/gm serotonin (5-HT) while the amine content in the aqueous humor is less than 0.01 ng/100 microliter. The low levels of endogenous 5-HT in the iris-ciliary body could not be directly detected by immunocytochemistry. However, pretreatment in vivo and in vitro with L-tryptophan and pargyline resulted in the localization of a sparse population of 5-HT fibers. These fibers could not be studied by exposing the tissue to exogenous 5-HT since the amine was taken up by noradrenergic fibers as well. This was confirmed in studies involving superior cervical ganglionectomy. It is concluded that 5-HT is taken up by both serotonergic and adrenergic fibers of the iris-ciliary body. In the presence of lithium, 5-HT stimulated an increase in the 3H-inositol phosphate accumulation in a dose-dependent manner in tissue where the phosphoinositide pool was labeled with 3H-inositol. A variety of agonists and antagonists were used to show that the 5-HT response is mediated, at least partly, by 5-HT2 receptors. The 5-HT-mediated effect on inositol phosphates is unaffected by superior cervical ganglionectomy. The effect of noradrenaline, which also stimulates inositol phosphate accumulation (but via alpha 1-adrenergic receptors in the iris-ciliary body), was elevated following superior cervical ganglionectomy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3193177      PMCID: PMC6569612     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  12 in total

1.  Ecstasy induced acute bilateral angle closure and transient myopia.

Authors:  Rajesh S Kumar; John Grigg; Adrian C Farinelli
Journal:  Br J Ophthalmol       Date:  2007-05       Impact factor: 4.638

2.  Expression of serotonin receptor mRNAs in human ciliary body: a polymerase chain reaction study.

Authors:  Glyn Chidlow; Paul S Hiscott; Neville N Osborne
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-02-10       Impact factor: 3.117

3.  The effects of a selective 5-HT2 receptor antagonist (ICI 170,809) on platelet aggregation and pupillary responses in healthy volunteers.

Authors:  D S Millson; C L Jessup; A Swaisland; S Haworth; A Rushton; J D Harry
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

4.  The effects of a 5-HT2 receptor antagonist (ICI 169,369) on changes in waking EEG, pupillary responses and state of arousal in human volunteers.

Authors:  D S Millson; S J Haworth; A Rushton; D Wilkinson; S Hobson; J Harry
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

Review 5.  Ocular adverse effects of common psychotropic agents: a review.

Authors:  Sami Richa; Jean-Claude Yazbek
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

6.  Ocular hypotensive effect of topical ketanserin in timolol users.

Authors:  L Mastropasqua; M Ciancaglini; P Carpineto; C Costagliola
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

7.  Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure.

Authors:  Ciro Costagliola; Francesco Parmeggiani; Francesco Semeraro; Adolfo Sebastiani
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

8.  Comparison of ketanserin, buspirone and propranolol on arousal, pupil size and autonomic function in healthy volunteers.

Authors:  Vassilis Koudas; Alexandra Nikolaou; Eugenia Hourdaki; Stella G Giakoumaki; Panos Roussos; Panos Bitsios
Journal:  Psychopharmacology (Berl)       Date:  2009-03-14       Impact factor: 4.530

9.  Effect of topical ketanserin administration on intraocular pressure.

Authors:  C Costagliola; G Iuliano; M Rinaldi; V Russo; G Scibelli; L Mastropasqua
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

Review 10.  SSRIs and intraocular pressure modifications: evidence, therapeutic implications and possible mechanisms.

Authors:  Ciro Costagliola; Francesco Parmeggiani; Adolfo Sebastiani
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.